Searchable abstracts of presentations at key conferences in endocrinology

ea0084op-11-56 | Oral Session 11: Young Investigators / Basic | ETA2022

Focusing on the role of the enigmatic TRα2 isoform in modulation of thyroid hormone action

Harting Nina , Eckhold Juliane , Sebastian Hones G. , Mittag Jens , J. Kaiser Frank

Thyroid hormones (TH) are important regulators of human metabolism and development, which modulate expression of target genes via nuclear thyroid hormone receptors (TRs). Different isoforms of these classical TRs including TRβ isoforms TRβ1 and TRβ2 as well as TRα1 were shown to be functional TH-responsive transcription factors and have been extensively studied. In contrast, the cellular function of TRα2, an alternative splice variant of TRα1, is ...

ea0038p208 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Bile acids stimulate GLP-1 release predominantly by accessing basolateral GPBAR1 (TGR5)

Brighton Cheryl A , Rievaj Juraj , Kuhre Rune E , Glass Leslie L , Holst Jens J , Gribble Fiona M , Reimann Frank

Background: Glucagon-like peptide 1 (GLP-1) is an incretin hormone released from enteroendocrine L-cells in the gut. GLP-1 analogues and dipeptidyl-peptidase-4 inhibitors are currently used to treat type-2 diabetes. A greater understanding of the mechanisms underlying the release of GLP-1 may facilitate the development of therapeutics to stimulate the release of endogenous GLP-1. Bile acids have been shown to induce GLP-1 release via the G protein-coupled bile acid receptor 1 ...

ea0070aep775 | Pituitary and Neuroendocrinology | ECE2020

FSH levels are related to E-cadherin expression and subcellular location in non-functioning pituitary neuroendocrine tumours

Jensen Kolnes Anders , Astrid Berland Øystese Kristin , Olarescu Cristina , Casar-Borota Olivera , Bollerslev Jens , Jørgensen Anders

Objectives: To study the effect of epithelial-to-mesenchymal transition (EMT) on hormone expression in gonadotroph non-functioning pituitary neuroendocrine tumours (NF-PitNET).Background: Gonadotroph PitNETs can express FSH and LH or be hormone negative, however they rarely secrete hormones. During tumour development, epithelial cells develop a mesenchymal phenotype. This process is characterised by decreased membranous E-cadherin and translocation of E-...

ea0014p210 | (1) | ECE2007

Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans

Gormsen Lars , Nielsen Charlotte , Jessen Niels , Vestergaard Esben , Christiansen Jens , Jørgensen Jens , Møller Niels

Background: Physiological elevations of free fatty acids (FFAs) occur in a dynamic bell-shaped fashion lasting some hours, e.g. nocturnally and during exercise. In order to define the metabolic role of physiological elevations in relation to diurnal fluctuations in insulin sensitivity, the present study was designed to identify the metabolic effects of a dynamic 4 hour elevation of FFAs during a glucose clamp.Materials and methods: 8 lean, healthy men we...

ea0014p475 | (1) | ECE2007

Six months physiological DHEA substitution in female adrenal failure: impact on quality of life and sexual parameters.

Christiansen Jens J , Mehlsen Mimi , Geraldi Anna Maria , Gravholt Claus , Jørgensen Jens O , Christiansen Jens S

Female adrenal failure involves impaired DHEA secretion and very low circulating androgens. To address the impact of a daily physiological substitution dose of capsule DHEA 50 mg on quality of life and sexual parameters, we performed a 6 month trial in a randomised, crossover and placebo controlled design. The trial was approved by the local ethical committee and conducted according to GCP guidelines. Ten patients were enrolled. Seven patients reported seborrhoic side effects ...

ea0073aep507 | Pituitary and Neuroendocrinology | ECE2021

Treatment regimens affecting glucose metabolism and gastrointestinal hormones in acromegaly: A descriptive study

Nanna Jørgensen , Erichsen Trine , Klose Marianne , Joergensen Morten , Idorn Thomas , Feldt-Rasmussen Bo , Holst Jens J. , Feldt-Rasmussen Ulla

ContextActive acromegaly is associated with impaired glucose metabolism, which improves upon treatment. Treatment options include surgery, medical therapy with somatostatin analogues (SSA) and Pegvisomant (PEG) and in few cases irradiation.ObjectiveTo describe the differential effect of various treatment regimens on the secretion of glucose, insulin, glucagon, glucagon-like peptide-1 (GLP1), and glucose-depen...